The global skin antiseptic market holds a valuation of USD 1.7 Billion in 2022, and it is further projected to expand at a CAGR of 6.7% over the forecasted years. According to a recent study by Future Market Insights, alcohols segment by product is leading the market with a share of about 48.1% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2023 | USD 1.8 Billion |
| Market Value 2033 | USD 3.4 Billion |
| CAGR 2023 to 2033 | 6.7% |
| Market Share of Top 5 Countries | 56.4% |
| Key Market Players | BODE Chemie GmbH, Dr. Schumacher GmbH, Ecolab, MaiMed GmbH, Schülke & Mayr GmbH, Terapima Sweden AB, B. Braun SE, 3M, BD, Reckitt Beckinser, Purdue Pharma L.P., PSK Pharma Pvt. Ltd., Halyard (Kimberly Clark), Sirmaxo Chemicals Pvt Ltd, Avrio Health L.P., Sage Products Ltd, Johnson and Johnson, Xttrium Laboratories, Mölnlycke Health Care AB, PDI, Inc., Microgen |
Skin antiseptics are substances that are applied to the skin to reduce or prevent the growth of microorganisms that can cause infection, sepsis, or putrefaction. They are similar to disinfectants, but are specifically designed for use on living tissue. Skin antiseptics are commonly used in healthcare facilities to reduce the burden of organisms on the skin and prevent infections.
They are often used for cleaning wounds and preventing the growth of microorganisms on the skin and mucous membranes. Skin antiseptics come in various forms, including liquids, gels, and wipes, and can contain different active ingredients such as alcohol, chlorhexidine, and Peroxides and Permanganates.
Explore FMI!
Book a free demo
The global sales of the skin antiseptic market are anticipated to rise at a CAGR of 6.7% between 2023 and 2033, owing to the rising number of surgical procedures, increasing prevalence of infectious diseases, growing awareness of the importance of infection prevention, and development of new and innovative products.
The global skin antiseptic market holds around 24.0% share of the overall global medicated skin care products market with a value of around USD 7.1 Billion, in 2022.
Skin antiseptics are used to reduce the microbial count on the skin and prevent the risk of surgical site infections (SSIs) and other infections like wounds. They are used in various healthcare settings, including hospitals, clinics, and long-term care facilities and in domestic care as well, to reduce the burden of organisms on the skin and prevent the spread of infections.
Skin antiseptics work by limiting the number of microorganisms on the skin, which reduces the risk of infection. The expansion of the global market is attributed to the increasing number of surgeries, higher number of hospital-acquired infections (HAIs), and the rising demand for prevention of infection spread and control measures.
The market is also driven by the development of new and innovative products, such as antiseptic wipes and sprays, and the increasing awareness of hygiene and infection control in the general population. The healthcare industry is the largest market for skin antiseptics, with hospital pharmacies being the primary distribution channel. As the global need for antiseptics grows, so does the need for new antiseptic products. Innovative product development can reduce the adverse effects of chemical disinfectants.
Recent developments in disinfection include the creation of surface coatings that pop coronaviruses, among other things. According to Dr. Hugo Macedo, CEO of the air filtration technology company Smart Separations, the coronavirus is destroyed on contact by an anti-microbial coating, which also aids in keeping the body clean. Synthetic antimicrobial peptides (mini-proteins) used in the coating cause the virus's outer lipid membrane to rupture, killing it instantly. A balloon being touched by a cactus causes the microbe to explode when this technique is used.
Owing to the above-mentioned factors, the global skin antiseptic market is expected to grow at a prominent pace, and reach a valuation of around USD 3.4 Billion during the year 2033.
The use of personal hygiene products has increased manifold in the last two years due to the COVID-19 pandemic. This growth is seen primarily to reduce the chances of infection caused due to COVID-19. People are increasingly concerned with cleanliness, hygiene, and keeping themselves and their surroundings germ-free.
To stop the spread of microorganism in the duration of COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) suggested use of a hand sanitizer with minimum 60% alcohol or hand wash with soap and water for at least 20 seconds.
Post pandemic, professionals at healthcare settings have been constantly reminded of the simple practice of keeping their hands clean either with soap and clean water or sanitizers to prevent the spread of germs and viruses. Further, increase in cases of hospital acquired infections, which is usually the case across various healthcare facilities, it has become more important to reduce the chances of infection spread to minimal. This is achieved through proper disinfection and sanitization of the medical instruments before and post use.
The disinfection of medical devices prevents the spread of disease from one patients to others. Post-operative or after surgical procedure sepsis, urinary tract infections during catheter use, blood stream infections, and pneumonia are the important types of hospital-acquired infections (HAIs) in adults.
Growing awareness regarding personal hygiene and availability of cost-effective products, as offered by many domestic players, will provide lucrative opportunities to the market players going forward.
Most of the antiseptics available in the market may cause skin allergies and skin infection when not used properly. When the antiseptics are applied on diseased or injured skin such as an eczematous skin, under inadequate occlusion or at too high concentrations, they may lead to severe skin allergies and infections.
For instance, Chlorhexidine is a key compound of antiseptic that commonly develop skin allergies and irritation. Also, it is very difficult for the dermatologist because it can cause wide range of health issues in the person.
Few people develop rapid chlorhexidine allergy because contact with chlorhexidine results in immune cells activation and histamine release in tissues. This can result in a variety of allergic reactions (anaphylaxis) like urticarial (hives), itching, and swelling (angioedema) along with dizziness, difficulty in breathing, and a low blood pressure or even collapse.
Users may not use skin antiseptics correctly or consistently due to a lack of awareness and compliance with infection prevention procedures. Antibiotics, vaccinations, and disinfectants are examples of alternative products for infection prevention that can compete with skin antiseptics.
The USA dominates the global market with market share of around 31.4% in global market 2022 due to development of significant adoption of skin antiseptics products resulting in the development of new and improved skin antiseptics that friendly to skin, and cause lesser side effects.
In the USA, there is an increasing focus on patient safety and infection control, which has increased the usage of skin antiseptics in healthcare institutions. The usage of skin antiseptics in healthcare institutions has increased as a result of the USA government's initiatives to improve infection prevention and control.
China holds a market share of 8.6% in the global skin antiseptic market 2022 due to growing demand for hygiene and infection prevention products.
There has been a significant increase in demand for hygiene and infection prevention products, notably skin antiseptics, as a result of the ongoing COVID-19 epidemic and growing awareness of the hazards of infections. Online skin antiseptic purchases are on the rise and are anticipated to stay that way in the future as e-commerce in China keeps expanding.
The healthcare sector in China is rapidly expanding, and this is leading to an increase in the demand for skin antiseptics in healthcare facilities.
Germany holds a market share of 6.5% in the global skin antiseptic market 2022 due to rising prevalence of hospital-associated infections, and growing demand for infection prevention products.
Healthcare-associated infections (HAIs) are a major concern in Germany, and skin antiseptics are an important measure for preventing the spread of HAIs. There is a growing demand for infection prevention products, including skin antiseptics, as consumers become more aware of the risks associated with infections and the importance of hand hygiene.
The German government has strict regulations regarding the use of skin antiseptics in healthcare facilities, which has led to an increase in the demand for these products.
India holds a share of around 41.2% in the South Asia market in 2022.
Consumers in India have a preference for herbal and natural products, and this trend is also being seen in the skin antiseptic market. Alcohol-based skin antiseptics are becoming more popular in India due to their effectiveness against a broad range of microorganisms and their ease of use. Combination products that combine skin antiseptics with other agents, such as moisturizers or emollients, are becoming more popular in India.
By product segment, alcohols held market share at about 48.1% in the global market 2022. Alcohol-based skin antiseptics are a popular and effective option for infection prevention and control.
Alcohol-based skin antiseptics are effective against a wide range of microorganisms, including bacteria, viruses, and fungi, making them a versatile option for infection prevention and control.
Alcohol-based skin antiseptics are easy to use and require no water or towels, making them a convenient option for use in a variety of settings. Hand sanitizers, which are alcohol-based skin antiseptics for use on hands, have become increasingly popular due to their convenience and effectiveness. After COVID-19 pandemic, the use of alcohol-based hand sanitizers is increased.
By form segment, solution held market share at about 38.0% in the global market 2022. Solution form of skin antiseptics can be used in a wide range of applications, including surgical site preparation, venipuncture, and catheter insertion. Solution form skin antiseptics are easy to use and require no water or towels, making them a convenient option for use in a variety of settings.
Preoperative skin antisepsis is used to lower the incidence of post-operative wound infections by cleaning the skin surface areas for removal of dirt and microorganisms.
Supermarket/Hypermarket hold a market share of 34.5% in the global market 2022. Skin antiseptic products from numerous brands are readily available in supermarkets and hypermarkets, making them easily accessible to customers. Skin antiseptic solutions are frequently priced competitively in supermarkets and hypermarkets, giving them an economical option for consumers. Supermarkets and hypermarkets are frequently located in handy locations, allowing customers to buy skin antiseptic goods while conducting their regular shopping.
Supermarkets and hypermarkets are increasingly selling skin antiseptic treatments through internet channels, and consumers are increasingly purchasing these goods online. To address the changing demands and preferences of consumers, supermarkets and hypermarkets are providing new and creative skin antiseptic products.
To boost their market position, the top players are focused on collaborative arrangements with other market participants and research organizations.
The companies are focusing on speeding the pace of innovation, prioritizing important platforms and locations, and reorganizing operations, all while expanding their business globally through agreements and partnerships.
A few examples of strategies acquired by the key players
Similarly, recent developments related to companies manufacturing skin antiseptic products have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Historical Data Available for | 2012 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United kingdom, Germany, Italy, Russia, Spain, France, Benelux, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries and South Africa |
| Key Market Segments Covered | Product, Form, Distribution Channel, and Region |
| Key Companies Profiled |
BODE Chemie GmbH; Dr. Schumacher GmbH; Ecolab; MaiMed GmbH; Schülke & Mayr GmbH; Terapima Sweden AB; B. Braun SE; 3M; BD; Reckitt Beckinser; Purdue Pharma L.P.; PSK Pharma Pvt. Ltd; Halyard (Kimberly Clark); Sirmaxo Chemicals Pvt Ltd; Avrio Health L.P.; Sage Products Ltd; Johnson and Johnson; Xttrium Laboratories; Mölnlycke Health Care AB; PDI, Inc.; Microgen |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The market is valued at USD 1.8 billion in 2023.
The global market size is to reach USD 3.4 billion by 2033.
BODE Chemie GmbH, Dr. Schumacher GmbH, and Ecolab are key players in the market.
Most antiseptics available in the market may cause skin allergies and infections when not used properly. This limits growth.
The market is likely to expand at a CAGR of 6.7% by 2033.
Generalized Myasthenia Gravis Management Market - Growth & Treatment Advances 2025 to 2035
Hutchinson-Gilford Progeria Syndrome Market Growth – Innovations & Therapies 2025 to 2035
Home Infusion Therapy Devices Market - Growth & Forecast 2025 to 2035
Human Combinatorial Antibody Libraries (HuCAL) Market - Trends & Forecast 2025 to 2035
Home Healthcare Market Growth - Trends, Innovations & Forecast 2025 to 2035
Dental 3D Printing Material Market Trends, Growth & Forecast by Material, Product, and Region through 2035
Skin Antiseptic Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
